NASDAQ:TLAB Tellabs (TLAB) Stock Price, News & Analysis → Putin and other countries have a plan (From Whats On Finance) (Ad) Free TLAB Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Tellabs alerts: Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About Tellabs Stock (NASDAQ:TLAB)Tellabs, Inc. is engaged in designing and marketing equipment and services to communications-services providers worldwide. The company operates in four segments: optical, data, access and services. Its products and services, in combination with its Tellabs 8000 Intelligent Network Manager, enables its customers to deliver wireless and wireline voice, data and video services to business and residential customers. It sells its products domestically and internationally through its field sales force and distributors/partners. In December 2013, Marlin Equity Partners LLC, through its Blackhawk Merger Sub Inc wholly-owned subsidiary, acquired the entire share capital of Tellabs Inc.Read More Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry TLAB Stock News HeadlinesOctober 4, 2023 | investing.comTLAB Historical DataJuly 12, 2023 | thestreet.comTellabs Stock To Go Ex-dividend Tomorrow (TLAB)April 23, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…April 4, 2023 | thestreet.comTellabs Stock Hits New 52-Week Low (TLAB)February 26, 2023 | msn.com'Serious Implications': Amarinder Singh On Pro-Khalistan Leader's ReleaseFebruary 26, 2023 | thestreet.comStocks Bounce Late to Finish FlatFebruary 26, 2023 | thestreet.comWhen Lightning StrikesJanuary 26, 2023 | thestreet.comBig Session, Little Session: Rally Comes on Miserable VolumeApril 23, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…January 19, 2023 | thestreet.comTurn a Triple Play With ArrisJanuary 15, 2023 | fortune.comTellabs, Inc.December 20, 2022 | thestreet.comMarket Preview: Facebook's FollyDecember 13, 2022 | financialpost.comCoastline Church Elevates Wi-Fi Connectivity, Reliability and Technology using Tellabs FlexAir with Optical LANMay 3, 2022 | thestreet.comTripAdvisor to Join S&P 500May 1, 2022 | thestreet.com10 Stocks to Watch: Netflix, 3MApril 8, 2022 | thestreet.com10 Best S&P 500 Stocks of the DecadeApril 6, 2022 | benzinga.comIntroducing Dwellwell™, the First-of-Its-Kind 'Check Engine Light' for Residential PropertiesMarch 17, 2022 | thestreet.comMarket Preview: Amazon On DeckMarch 13, 2022 | thestreet.comMarket Preview: Running Out of SteamFebruary 14, 2022 | thestreet.comNew Life in Net/Net StocksSee More Headlines Receive TLAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tellabs and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryCommunications Equipment Current SymbolNASDAQ:TLAB CUSIP87966410 CIK317771 Webwww.tellabs.com Phone+1-630-7988800FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesVincent H. Tobkin (Age 63)Chairman of the Board Daniel P. Kelly (Age 51)President, Chief Executive Officer Lawrence A. Rieger (Age 62)Acting Chief Financial Officer James M. Sheehan (Age 50)Executive Vice President, Chief Administrative Officer, General Counsel, Secretary Roger J. Heinz (Age 50)Executive Vice President - Global Sales and Services John M. Brots (Age 52)Executive Vice President - Global Operations Kenneth G. Craft (Age 57)Executive Vice President - Product Development Michael Miles (Age 50)Chief Accounting Officer, Vice President - Finance Alex Mashinsky (Age 49)Director Bo C. Hedfors (Age 69)Independent Director More Executives TLAB Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Tellabs own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tellabs investors own include BG Medicine (BGMD), Abraxas Petroleum (AXAS), AVEO Pharmaceuticals (AVEO), Antares Pharma (ATRS), Athersys (ATHX), Assembly Biosciences (ASMB), ArQule (ARQL), Anthera Pharmaceuticals (ANTH), Amarin (AMRN) and ALU (ALU). This page (NASDAQ:TLAB) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsIncredible Opportunity to Retire FAST!Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tellabs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
